Medpace
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 4 in the most recent period (2026/Q4).
- Total institutional ownership fell 0.1 percentage points.
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 84.83% -0.12pp
- Institutions
- 910 -4
- As of
- 2026/Q4 vs. prior period
Holder types
Top holders as of 2026-09-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 18 buys · 29 sells
| Name | Role | Stake |
|---|---|---|
| August Troendle | Chief Executive Officer | 18.13% |
| Susan Burwig | Former Officer | 0.19% |
| Brian Carley | Independent Director | 0.10% |
| Stephen Ewald | Chief Compliance Officer, General Counsel & Corporate Secretary | 0.07% |
| Jesse Geiger | Former President | 0.05% |
| Kevin Brady | Chief Financial Officer | 0.05% |
| Cornelius McCarthy | Independent Director | 0.04% |
| Fred Davenport | Lead Independent Director | 0.02% |
| Robert Kraft | Independent Director | 0.00% |
| Brad Hansman | Officer | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-28 | Stephen Ewald | Chief Compliance Officer, General Counsel & Corporate Secretary | Open Market Disposition | -1,245 | $690.00 |
| 2026-10-26 | Susan Burwig | Former Officer | Open Market Disposition | -19,672 | $677.00 |
| 2026-10-26 | Susan Burwig | Former Officer | Derivative Exercise and Sale | -328 | $166.73–677.00 |
| 2026-10-26 | Susan Burwig | Former Officer | Intent to Sell (Form 144) | -3,940 | $677.00 |
| 2026-10-25 | Susan Burwig | Former Officer | Intent to Sell (Form 144) | -16,060 | $677.00 |
| 2026-10-20 | Susan Burwig | Former Officer | Derivative Exercise and Retained | +2,700 | $166.73 |
| 2026-10-11 | Susan Burwig | Former Officer | Derivative Exercise and Retained | +3,000 | $166.73 |
| 2026-10-06 | Susan Burwig | Former Officer | Derivative Exercise and Retained | +2,000 | $166.73 |
| 2026-09-29 | Cornelius McCarthy | Independent Director | Derivative Exercise and Retained | +28 | -- |
| 2026-09-29 | August Troendle | Chief Executive Officer | Open Market Disposition | -48,667 | $621.02–625.47 |
| 2026-09-29 | Robert Kraft | Independent Director | Derivative Exercise and Retained | +32 | -- |
| 2026-09-29 | Brian Carley | Independent Director | Derivative Exercise and Retained | +36 | -- |
| 2026-09-27 | August Troendle | Chief Executive Officer | Open Market Disposition | -2,564 | $620.07–620.60 |
| 2026-09-23 | August Troendle | Chief Executive Officer | Open Market Disposition | -43,916 | $621.33–628.64 |
| 2026-09-21 | August Troendle | Chief Executive Officer | Open Market Disposition | -70,901 | $623.29–628.11 |
| 2026-09-16 | August Troendle | Chief Executive Officer | Open Market Disposition | -10,880 | $620.40 |
| 2026-09-15 | August Troendle | Chief Executive Officer | Open Market Disposition | -24,741 | $620.84–621.29 |
| 2026-09-14 | Susan Burwig | Former Officer | Derivative Exercise and Retained | +3,000 | $166.73 |
| 2026-08-26 | August Troendle | Chief Executive Officer | Open Market Disposition | -650 | $620.27 |
| 2026-08-25 | August Troendle | Chief Executive Officer | Open Market Disposition | -4,673 | $620.03–620.38 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Medpace discussion 0 comments